investorscraft@gmail.com

Intrinsic ValueVitasoy International Holdings Limited (0345.HK)

Previous CloseHK$6.99
Intrinsic Value
Upside potential
Previous Close
HK$6.99

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Vitasoy International Holdings Limited is a prominent Hong Kong-based manufacturer and distributor of plant-based food and beverages, operating primarily in the packaged foods sector. The company's core revenue model is built on the production and sale of a diverse portfolio including soya milk, other plant milks, teas, juices, water, and tofu products across key Asian and Australasian markets. Its operations extend beyond manufacturing to include direct retail through tuck shops, a catering business, beverage sales, and property investments, creating a multifaceted income stream. Vitasoy holds a strong market position as an early pioneer in plant-based nutrition, leveraging its long-established brand heritage since 1940 to maintain consumer trust and distribution dominance in its home market while expanding its footprint in Mainland China. The company competes in the competitive consumer defensive sector by emphasizing health, quality, and sustainability, targeting health-conscious consumers through extensive retail and distributor networks. Its strategic focus on Asia-Pacific growth markets, combined with its vertically integrated operations from manufacturing to retail, provides a resilient business model capable of navigating regional consumer trends and competitive pressures.

Revenue Profitability And Efficiency

Vitasoy generated HKD 6.27 billion in revenue for the period, achieving a net income of HKD 234.67 million. The company demonstrated solid operational cash flow generation of HKD 859 million, significantly exceeding its capital expenditures of HKD 124.69 million, indicating efficient cash conversion from its core business activities and prudent investment management.

Earnings Power And Capital Efficiency

The company reported diluted earnings per share of HKD 0.22, reflecting its earnings power from its diversified product portfolio and geographic operations. Strong operating cash flow relative to net income underscores effective working capital management and the capital-efficient nature of its manufacturing and distribution model.

Balance Sheet And Financial Health

Vitasoy maintains a robust balance sheet with HKD 1.27 billion in cash and equivalents against total debt of HKD 563.65 million. This substantial cash position, which exceeds total debt, provides significant financial flexibility and a very conservative leverage profile, supporting ongoing operations and strategic initiatives.

Growth Trends And Dividend Policy

The company has demonstrated a commitment to shareholder returns, distributing a dividend per share of HKD 0.142. This dividend policy, supported by strong cash generation, reflects a balanced approach to returning capital to shareholders while retaining funds for potential growth investments in its core markets and product expansion.

Valuation And Market Expectations

With a market capitalization of approximately HKD 9.35 billion, the market values Vitasoy at roughly 1.5 times revenue. The negative beta of -0.039 suggests the stock has exhibited low correlation with broader market movements, potentially being viewed as a defensive holding within the consumer staples sector.

Strategic Advantages And Outlook

Vitasoy's key advantages include its long-established brand equity, deep-rooted distribution networks in Asia, and expertise in plant-based products aligned with growing health trends. The outlook remains focused on leveraging these strengths to capture growth in expanding markets like Mainland China while navigating competitive and input cost pressures.

Sources

Company Annual ReportHong Kong Stock Exchange Filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount